{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:35:06Z","timestamp":1788586506053,"version":"build-2803163510"},"reference-count":58,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.2217\/fca-2023-0056","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T10:51:43Z","timestamp":1699354303000},"page":"661-670","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Obstructive Hypertrophic Cardiomyopathy: A Review of New Therapies"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8689-5839","authenticated-orcid":false,"given":"Nandini","family":"Mehra","sequence":"first","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center Heart Vascular Thoracic Institute Cleveland Clinic\r          Cleveland\r          OH\r          44195\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-1071","authenticated-orcid":false,"given":"Adel Hajj","family":"Ali","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center Heart Vascular Thoracic Institute Cleveland Clinic\r          Cleveland\r          OH\r          44195\r          USA"},{"name":"Department of Internal Medicine Indiana University\r          Indianapolis\r          IN\r          46202\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-9797","authenticated-orcid":false,"given":"Milind Y","family":"Desai","sequence":"additional","affiliation":[{"name":"Hypertrophic Cardiomyopathy Center Heart Vascular Thoracic Institute Cleveland Clinic\r          Cleveland\r          OH\r          44195\r          USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"e_1_3_5_3_1","first-page":"220","article-title":"Contribution \u00e0 l\u2019\u00e9tude des r\u00e9tr\u00e9cissements de l\u2019orifice ventriculo-aortique","volume":"3","author":"Vulpian A","year":"1868","unstructured":"Vulpian A . Contribution \u00e0 l\u2019\u00e9tude des r\u00e9tr\u00e9cissements de l\u2019orifice ventriculo-aortique. Arch. Physiol., 3, 220\u2013222 (1868).","journal-title":"Arch. Physiol."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.20.1.1"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2015.0354"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6120118"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc3701.095952"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311059"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16358-7"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000538"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1710575"},{"issue":"4","key":"e_1_3_5_12_1","first-page":"3","article-title":"Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients","volume":"30","author":"Braunwald E","year":"1964","unstructured":"Braunwald E , LambrewCT, RockoffSD, RossJJr, MorrowAG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation, 30(Suppl. 4), 3\u2013119 (1964).","journal-title":"Circulation"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.004"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.045"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.44.5.488"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.05.068"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.541"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01728-w"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(93)90386-F"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.27.701"},{"issue":"3","key":"e_1_3_5_21_1","first-page":"II42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell RP","year":"1988","unstructured":"Russell RP . Side effects of calcium channel blockers. Hypertension, 11(3 Pt 2), II42\u201344 (1988).","journal-title":"Hypertension"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197904263001705"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90553-X"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.012"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.112.000122"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70318-7"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005152"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004124"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002764"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2018.02.025"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70241-4"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308343"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.4847"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.064"},{"issue":"2","key":"e_1_3_5_35_1","first-page":"99","article-title":"[New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy]","volume":"39","author":"Malt\u00eas S","year":"2020","unstructured":"Malt\u00eas S , LopesLR. [New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy]. Rev. Port. Cardiol., 39(2), 99\u2013109 (2020).","journal-title":"Rev. Port. Cardiol."},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.52.1.88"},{"issue":"6","key":"e_1_3_5_37_1","first-page":"446","article-title":"The surgical management of obstructive cardiomyopathy","volume":"57","author":"Cleland WP","year":"1964","unstructured":"Cleland WP . The surgical management of obstructive cardiomyopathy. Proc. R. Soc. Med., 57(6), 446\u2013448 (1964).","journal-title":"Proc. R. Soc. Med."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91267-3"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011580"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2015.06.011"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.0252"},{"issue":"25","key":"e_1_3_5_42_1","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy","volume":"142","author":"Ommen SR","year":"2020","unstructured":"Ommen SR , MitalS, BurkeMAet al. 2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation, 142(25), e558\u2013e631 (2020).","journal-title":"Circulation"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5383.1690"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3456"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168407"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3016"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31792-X"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(21)01891-X"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.048"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.10.020"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062534"},{"key":"e_1_3_5_52_1","first-page":"1","volume-title":"FDA Medication Guide.","author":"MyoKardia IawosoB-MS","year":"2022","unstructured":"MyoKardia IawosoB-MS . Full prescribing information: camzyos. In: FDA Medication Guide.MyoKardia, Inc. a wholly owned subsidiary of Bristol-Myers Squibb, 1\u201327 (2022). https:\/\/packageinserts.bms.com\/pi\/pi_camzyos.pdf"},{"key":"e_1_3_5_53_1","volume-title":"StatPearls.","author":"Bello J","year":"2023","unstructured":"Bello J , PellegriniMV. Mavacamten. In: StatPearls.StatPearls Publishing, FL, USA (2023)."},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024656"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01290"},{"key":"e_1_3_5_56_1","volume-title":"Part of the European Society of Cardiology\u2019s (ESC) Heart Failure 2022.","author":"Ahmad Masri","year":"2022","unstructured":"Ahmad Masri . Efficacy and safety of aficamten inpatients with symptomatic obstructive hypertrophic cardiomyopathy. Presented at: Part of the European Society of Cardiology\u2019s (ESC) Heart Failure 2022.Madrid, Spain, 21\u201324 May 2022"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00021.2020"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02190-7"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02176-5"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02184-5"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca-2023-0056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T15:32:21Z","timestamp":1715959941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca-2023-0056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":58,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.2217\/fca-2023-0056"],"URL":"https:\/\/doi.org\/10.2217\/fca-2023-0056","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-04-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}